DE164054T1 - Verfahren zum nachweis von polymorphischen restriktionsstellen und nukleinsauren sequenzen. - Google Patents
Verfahren zum nachweis von polymorphischen restriktionsstellen und nukleinsauren sequenzen.Info
- Publication number
- DE164054T1 DE164054T1 DE198585106525T DE85106525T DE164054T1 DE 164054 T1 DE164054 T1 DE 164054T1 DE 198585106525 T DE198585106525 T DE 198585106525T DE 85106525 T DE85106525 T DE 85106525T DE 164054 T1 DE164054 T1 DE 164054T1
- Authority
- DE
- Germany
- Prior art keywords
- restriction site
- sample
- restriction
- nucleic acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6832—Enhancement of hybridisation reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Claims (8)
1. Verfahren zum Nachweis der Anwesenheit oder Abwesenheit mindestens einer bestimmten Restriktionsstelle in einer
bestimmten Nukleinsäure-Sequenz, gekennzeichnet durch die Stufen:
(a) Hybridisierung der Nukleinsäure-Sequenz mit einer Oligonukleotid-Probe für jede nachzuweisende Restriktionsstelle, wobei die Probe zu einem Bereich der Nukleinsäure-Sequenz
komplementär ist, der die entsprechende Restrik-
tionsstelle der Probe überspannt und wobei die Probe an
dem der jeweiligen Restriktionsstelle näheren Ende markiert ist;
(b) Verdauen der hybridisierten Nukleinsäure-Sequenz mit einer Restriktions-Endonuklease für jede Probe, wel-
ehe zur Spaltung der jeweiligen Probe an der nachzuweisenden
Restriktionsstelle befähigt ist, wobei markierte und unmarkierte oligomere Fragmente erhalten werden, bei
denen die Markierung die gleiche ist wie diejenige auf der Probe;
(c) Abtrennen aller markierten, gespalteten oligomeren Fragmente von markierten nichtgespalteten Oligomeren;
und
(d) Nachweis der Gegenwart oder Abwesenheit von markierten oligomeren Fragmenten.
35
L J
Γ *■·'■·· ■-•-»2--·..·'..· 0164052
2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß
es ein Verfahren zum Nachweis der Gegenwart einer Restriktionsstelle ist, deren Bezug zu einer Infektionskrankheit
bekannt ist.
3. Verfahren zum Nachweis der Gegenwart oder Abwesenheit von einem oder beiden Allelen einer polymorphen Restriktionsstelle in einer bestimmten Nukleinsäure-Sequenz, gekennzeichnet
durch die Stufen:
(a) Hybridisierung der Nukleinsäure-Sequenz mit einer Oligonukleotid-Probe, welche komplementär ist zu einem
Bereich in der Nukleinsäure-Sequenz, der eine nur in einem Alle! vorhandene erste Restriktionsstelle und eine beiden
Allelen gemeinsame zweite Restriktionsstelle überspannt, und wobei die Probe an einem Ende markiert ist, das sich
näher bei einer der genannten Restrictionsstellen befindet
;
(b) Verdauen der hybridisierten Nukleinsäure-Sequenz mit einer ersten Restriktionsendonuklease, welche zur Spaltung
der Probe nur an der ersten Restriktionsstelle befähigt ist, wobei markierte und unmarkierte oligomere
Fragmente erhalten werden, in denen die Markierung die gleiche wie diejenige an der Probe ist;
(c) Verdauen des Verdaus von Stufe (b) mit einer zweiten
Restriktionsendonuklease, welche zur Spaltung der Probe nur an der zweiten Restriktionsstelle befähigt ist, wobei
markierte und unmarkierte oligomere Fragmente erhalten werden, in denen die Markierung die gleiche wie diejenige
der Probe ist;
(d) Abtrennung aller markierten, gespalteten oligomeren
Fragmente von nichtgespalteten Oligomeren; und (e) Nachweis der Gegenwart oder Abwesenheit von markierten
Fragmenten mit bestimmten Basenlängen, die mit der Spaltung durch die erste oder zweite Restriktionsendonuklease
übereinstimmen.
4. Verfahren nach Anspruch 5? dadurch gekennzeichnet, daß
die Krankheit Sichelzellanämie ist, die erste Sestriktionsstelle die in normalem ß-Globin vorhandene, in Sichelzellen-fi-Globin
jedoch abwesende Ddel-Schnittstelle
ist, und die zweite Restriktionsstelle, die sowohl in normalem als auch in Sichelzellen-ß-Globin vorhandene
Hinf!-Schnittstelle ist.
5. "Verfahren nach einem der Ansprüche 1 bis 4, weiter da-
durch gekennzeichnet, daß nach der Stufe (a) und vor der Stufe (b) das Verfahren gekennzeichnet ist durch die
Stufen:
(a1) Versetzen des Hybridisierungsgemisches von Stufe (a)
mit einem unmarkierten blockierenden Oligomeren, das zu allen Proben mit Ausnahme von mindestens einem nicht richtig
zusammenpassenden Basenpaar an jeder nachzuweisenden Restriktionsstelle komplementär ist; und
(a") Hybridisieren des Hybridisierungsgemisches in Gegenwart des blockierenden Oligomeren.
6. Verfahren nach einem der Ansprüche 1 bis 5, dadurch gekennzeichnet,
daß die Restriktionsstelle polymorph ist und die Hybridisierungsstufe in Gegenwart eines positiven
Vergleichs-Oligomeren durchgeführt wird, das an einen Bereich der Nukleinsäure-Sequenz bindet, welcher eine nichtpolymorphe
Restriktionsstelle für die Restriktionsendonuklease enthält.
7· Verfahren nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet,
daß die Nukleinsäure-Sequenz eine DNA-Sequenz ist und die Probe ein Oligodeoxyribonukleotid ist.
8. Nachweissatz zum raschen Nachweis der Gegenwart oder Abwesenheit
mindestens einer bestimmten Restriktionsstelle in einer bestimmten Nukleinsäure-Sequenz, gekennzeichnet
durch:
L J
- ·ι+- 01
(a) eine Cligonukleotid-Probe für ,jede nachzuweisende Restriktionsstelle,
wobei die Probe zu einem Bereich der Nukleinsäure-Sequenz komplementär ist, der die betreffende
Restrik~ionsstelle der Probe überspannt, und wobei die
Probe an dem der betreffenden Restriktionsstelle näheren
Ende markiert ist; und
(b) eine Restriktionsendonuklease für jede Probe, die zur
Spaltung der Probe an der Restriktionsstelie befähigt ist.
9· Nachweissatz nach Anspruch 8, weiter gekennzeichnet durch
ein nichtmarkiertes blockierendes Oligomeres, das zu allen Proben mit Ausnahme von mindestens einem nichtpassenden
Basenpaar an der Restriktionsstelle komplementär ist.
1C. Nachweissatz zum Nachweis der Gegenwart oder Abwesenheit von einem oder beiden Allelen einer poiymorphen Restriktionsstelle
in einer bestimmten DNA-Sequenz, gekennzeichnet durch:
(a) eine Oligodeoxyribonukleotid-Probe, welche zu einem Bereich in der DNA-Sequenz komplementär ist, der eine erste, nur in einem Allel vorhandene Restriktionsstelle und eine zweite, beiden Allelen gemeinsame Restriktionsstellle überspannt und wobei die Probe an dem zu einer der Restriktionsstellen näheren Ende markiert ist; ("b) eine erste Restriktionsendonuklease, die zur Spaltung der Probe nur an der ersten Restriktionsstelle befähigt ist; und
(a) eine Oligodeoxyribonukleotid-Probe, welche zu einem Bereich in der DNA-Sequenz komplementär ist, der eine erste, nur in einem Allel vorhandene Restriktionsstelle und eine zweite, beiden Allelen gemeinsame Restriktionsstellle überspannt und wobei die Probe an dem zu einer der Restriktionsstellen näheren Ende markiert ist; ("b) eine erste Restriktionsendonuklease, die zur Spaltung der Probe nur an der ersten Restriktionsstelle befähigt ist; und
(c) eine zweite Restriktionsendonuklease, die zur Spaltung der Probe nur an der zweiten Restriktionsstelle
befähigt ist.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61495784A | 1984-05-29 | 1984-05-29 | |
US06/716,982 US4683194A (en) | 1984-05-29 | 1985-03-28 | Method for detection of polymorphic restriction sites and nucleic acid sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
DE164054T1 true DE164054T1 (de) | 1986-04-30 |
Family
ID=27087371
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585106525T Expired DE3572693D1 (en) | 1984-05-29 | 1985-05-28 | Method for detection of polymorphic restriction sites and nucleic acid sequences |
DE198585106525T Pending DE164054T1 (de) | 1984-05-29 | 1985-05-28 | Verfahren zum nachweis von polymorphischen restriktionsstellen und nukleinsauren sequenzen. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585106525T Expired DE3572693D1 (en) | 1984-05-29 | 1985-05-28 | Method for detection of polymorphic restriction sites and nucleic acid sequences |
Country Status (9)
Country | Link |
---|---|
US (1) | US4683194A (de) |
EP (1) | EP0164054B1 (de) |
JP (1) | JPS6119500A (de) |
AU (1) | AU587189B2 (de) |
CA (1) | CA1242627A (de) |
DE (2) | DE3572693D1 (de) |
DK (1) | DK240285A (de) |
ES (1) | ES8608584A1 (de) |
IL (1) | IL75327A (de) |
Families Citing this family (306)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5582970A (en) * | 1982-11-03 | 1996-12-10 | City Of Hope | Competitive hybridization technique |
US4775619A (en) * | 1984-10-16 | 1988-10-04 | Chiron Corporation | Polynucleotide determination with selectable cleavage sites |
US5430136A (en) * | 1984-10-16 | 1995-07-04 | Chiron Corporation | Oligonucleotides having selectably cleavable and/or abasic sites |
US4820630A (en) * | 1984-11-23 | 1989-04-11 | Digene Diagnostics, Incorporated | Assay for nucleic acid sequences, particularly genetic lesions, using interactive labels |
US5656493A (en) * | 1985-03-28 | 1997-08-12 | The Perkin-Elmer Corporation | System for automated performance of the polymerase chain reaction |
US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US5038852A (en) * | 1986-02-25 | 1991-08-13 | Cetus Corporation | Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
US5008182A (en) * | 1986-01-10 | 1991-04-16 | Cetus Corporation | Detection of AIDS associated virus by polymerase chain reaction |
US5176995A (en) * | 1985-03-28 | 1993-01-05 | Hoffmann-La Roche Inc. | Detection of viruses by amplification and hybridization |
US5333675C1 (en) * | 1986-02-25 | 2001-05-01 | Perkin Elmer Corp | Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
JPH0665320B2 (ja) * | 1985-07-10 | 1994-08-24 | ザ リサ−チ フアウンデ−シヨン オブ ステ−ト ユニバ−シテイ− オブ ニユ−ヨ−ク | 遺伝子の新規検出法 |
US4876187A (en) * | 1985-12-05 | 1989-10-24 | Meiogenics, Inc. | Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences |
CA1339653C (en) * | 1986-02-25 | 1998-02-03 | Larry J. Johnson | Appartus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps |
CA1284931C (en) * | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
US5604099A (en) * | 1986-03-13 | 1997-02-18 | Hoffmann-La Roche Inc. | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
GB8606719D0 (en) * | 1986-03-19 | 1986-04-23 | Lister Preventive Med | Genetic probes |
US5218099A (en) * | 1986-04-01 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Post-transfusion, non-A, non-B hepatitis virus polynucleotides |
FR2603047B1 (fr) * | 1986-08-19 | 1990-03-02 | Vassart Gilbert | Sonde d'hybridation pour la detection de sequences nucleotidiques polymorphes contenues dans un echantillon d'adn humain ou animal, procede de detection de sequences d'adn polymorphes utilisant une telle sonde, ses applications biologiques |
US4889818A (en) * | 1986-08-22 | 1989-12-26 | Cetus Corporation | Purified thermostable enzyme |
CA1338457C (en) * | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
US4987066A (en) * | 1986-11-07 | 1991-01-22 | Max Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Process for the detection of restriction fragment length polymorphisms in eukaryotic genomes |
US5079351A (en) * | 1986-11-26 | 1992-01-07 | Cetus Corporation | Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization |
US5428163A (en) * | 1986-12-31 | 1995-06-27 | Mills; Randell L. | Prodrugs for selective drug delivery |
EP0294098A1 (de) * | 1987-05-29 | 1988-12-07 | City Of Hope | Synthetische DNS-Proben |
GB8716367D0 (en) * | 1987-07-10 | 1987-08-19 | Reeders S T | Genetic identification |
US4994368A (en) | 1987-07-23 | 1991-02-19 | Syntex (U.S.A.) Inc. | Amplification method for polynucleotide assays |
US5273879A (en) * | 1987-07-23 | 1993-12-28 | Syntex (U.S.A.) Inc. | Amplification method for polynucleotide assays |
DE3851810T2 (de) * | 1987-07-31 | 1995-02-09 | Gen Probe Inc | Polynukleotidentest unter Benutzung von Oligonukleotiden zur Eliminierung von unerwünschten Kreuzreaktionen. |
WO1989001050A1 (en) | 1987-07-31 | 1989-02-09 | The Board Of Trustees Of The Leland Stanford Junior University | Selective amplification of target polynucleotide sequences |
US6090591A (en) * | 1987-07-31 | 2000-07-18 | The Board Of Trustees Of The Leland Stanford Junior University | Selective amplification of target polynucleotide sequences |
US6004745A (en) * | 1987-09-21 | 1999-12-21 | Gen-Probe Incorporated | Hybridization protection assay |
DE3854029T2 (de) * | 1987-09-21 | 1995-10-26 | Gen Probe Inc | Homogener Abschirmungstest. |
US5639604A (en) * | 1987-09-21 | 1997-06-17 | Gen-Probe Incorporated | Homogeneous protection assay |
US5283174A (en) * | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
JP2634208B2 (ja) * | 1987-11-13 | 1997-07-23 | パイオニア・ハイ―ブレツド・インターナシヨナル・インコーポレイテツド | 制限断片長多型性分析方法及びその装置 |
FI79342C (fi) * | 1987-12-23 | 1989-12-11 | Orion Yhtymae Oy | Apparat, del av en apparat och foerfarande foer maongfaldigande av nukleinsyror. |
EP0333465B1 (de) * | 1988-03-18 | 1994-07-13 | Baylor College Of Medicine | Mutationsnachweis durch kompetitiven Oligonukleotid-Priming |
CA1341077C (en) * | 1988-03-31 | 2000-08-08 | Randell L. Mills | Luminide and macroluminide class of pharmaceuticals |
AU3974989A (en) * | 1988-07-26 | 1990-02-19 | Genelabs Incorporated | Sequence-specific amplification techniques |
US5185243A (en) * | 1988-08-25 | 1993-02-09 | Syntex (U.S.A.) Inc. | Method for detection of specific nucleic acid sequences |
US5389512A (en) * | 1988-10-07 | 1995-02-14 | Hoffman-La Roche Inc. | Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction |
US5508199A (en) * | 1989-01-03 | 1996-04-16 | The United States Of America As Represented By The Department Of Health And Human Services | P450db1 clones for identifying humans with genetic defect in drug metabolism |
GB8902689D0 (en) * | 1989-02-07 | 1989-03-30 | Ici Plc | Assay method |
EP0481999B1 (de) * | 1989-03-10 | 1997-07-23 | VYSIS, Inc. | Interferenzverhinderung mit affinitätseinfangschemas |
US5075217A (en) * | 1989-04-21 | 1991-12-24 | Marshfield Clinic | Length polymorphisms in (dC-dA)n ·(dG-dT)n sequences |
US5091302A (en) * | 1989-04-27 | 1992-02-25 | The Blood Center Of Southeastern Wisconsin, Inc. | Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof |
FR2650839A1 (fr) * | 1989-08-08 | 1991-02-15 | Oris Ind Cie | Procede de detection en phase homogene liquide de sequences specifiques d'acides nucleiques et ses applications |
US20040197775A1 (en) * | 1989-08-25 | 2004-10-07 | Genetype A.G. | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
US5192659A (en) * | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
US5451502A (en) * | 1990-05-04 | 1995-09-19 | Oncor, Inc. | Restriction amplification assay |
US5556747A (en) * | 1990-07-09 | 1996-09-17 | E. R. Squibb & Sons, Inc. | Method for site-directed mutagenesis |
US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
KR100236506B1 (ko) * | 1990-11-29 | 2000-01-15 | 퍼킨-엘머시터스인스트루먼츠 | 폴리머라제 연쇄 반응 수행 장치 |
US5518900A (en) * | 1993-01-15 | 1996-05-21 | Molecular Tool, Inc. | Method for generating single-stranded DNA molecules |
US5273883A (en) * | 1991-05-07 | 1993-12-28 | Hoffmann-La Roche Inc. | Methods and reagents for γ-globin typing |
US5169766A (en) * | 1991-06-14 | 1992-12-08 | Life Technologies, Inc. | Amplification of nucleic acid molecules |
CA2075858C (en) * | 1991-08-15 | 1998-05-19 | Scott J. Eisenbeis | Detection of complementary nucleotide sequences |
US5846717A (en) | 1996-01-24 | 1998-12-08 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
US5994069A (en) * | 1996-01-24 | 1999-11-30 | Third Wave Technologies, Inc. | Detection of nucleic acids by multiple sequential invasive cleavages |
US6872816B1 (en) | 1996-01-24 | 2005-03-29 | Third Wave Technologies, Inc. | Nucleic acid detection kits |
DK0549107T3 (da) | 1991-10-11 | 1998-08-31 | Dade Behring Marburg Gmbh | Fremgangsmåde til fremstilling af et polynukleotidtil anvendelse ved enkeltprimeramplifikation og phosphorthioatholdige oli |
US5612199A (en) * | 1991-10-11 | 1997-03-18 | Behringwerke Ag | Method for producing a polynucleotide for use in single primer amplification |
US5567583A (en) * | 1991-12-16 | 1996-10-22 | Biotronics Corporation | Methods for reducing non-specific priming in DNA detection |
US6033854A (en) * | 1991-12-16 | 2000-03-07 | Biotronics Corporation | Quantitative PCR using blocking oligonucleotides |
US5348853A (en) * | 1991-12-16 | 1994-09-20 | Biotronics Corporation | Method for reducing non-specific priming in DNA amplification |
WO1993014217A1 (en) * | 1992-01-10 | 1993-07-22 | Life Technologies, Inc. | Use of predetermined nucleotides having altered base pairing characteristics in the amplification of nucleic acid molecules |
US5354442A (en) * | 1992-05-21 | 1994-10-11 | The United States Of America As Represented By The Secretary Of The Commerce | Matrix modification in the electrophoretic separation of nucleic acids |
ES2104160T3 (es) * | 1992-07-31 | 1997-10-01 | Behringwerke Ag | Metodo para introducir secuencias definidas en el extremo 3' de polinucleotidos. |
US6261808B1 (en) | 1992-08-04 | 2001-07-17 | Replicon, Inc. | Amplification of nucleic acid molecules via circular replicons |
US5614389A (en) * | 1992-08-04 | 1997-03-25 | Replicon, Inc. | Methods for the isothermal amplification of nucleic acid molecules |
US5834202A (en) | 1992-08-04 | 1998-11-10 | Replicon, Inc. | Methods for the isothermal amplification of nucleic acid molecules |
US5733733A (en) * | 1992-08-04 | 1998-03-31 | Replicon, Inc. | Methods for the isothermal amplification of nucleic acid molecules |
WO1994003624A1 (en) * | 1992-08-04 | 1994-02-17 | Auerbach Jeffrey I | Methods for the isothermal amplification of nucleic acid molecules |
US6436635B1 (en) * | 1992-11-06 | 2002-08-20 | Boston University | Solid phase sequencing of double-stranded nucleic acids |
US5795714A (en) * | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
US20060257885A1 (en) * | 1993-01-05 | 2006-11-16 | Gelfand David H | Homogeneous assay system |
US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
US6610654B2 (en) * | 1993-03-31 | 2003-08-26 | Wellstat Therapeutics Corporation | Inhibitor of stem cell proliferation and uses thereof |
US5939391A (en) * | 1993-03-31 | 1999-08-17 | Pro-Neuron, Inc. | Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
AU694111B2 (en) * | 1993-03-31 | 1998-07-16 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
US6294323B1 (en) | 1993-04-14 | 2001-09-25 | Behringwerke Ag | Self initiating single primer amplification of nucleic acids |
US5741645A (en) * | 1993-06-29 | 1998-04-21 | Regents Of The University Of Minnesota | Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
US5834183A (en) * | 1993-06-29 | 1998-11-10 | Regents Of The University Of Minnesota | Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
AU692816B2 (en) * | 1993-07-19 | 1998-06-18 | Gen-Probe Incorporated | Oligonucleotide screening assay |
US6680378B1 (en) * | 1993-10-28 | 2004-01-20 | Invitrogen Corporation | Nucleic acid marker ladder for estimating mass |
EP0726905B1 (de) * | 1993-11-03 | 2005-03-23 | Orchid BioSciences, Inc. | Polymorphismus von mononukleotiden und ihre verwendung in der genanalyse |
AU8102694A (en) * | 1993-11-17 | 1995-06-06 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
CA2182517C (en) * | 1994-02-07 | 2001-08-21 | Theo Nikiforov | Ligase/polymerase-mediated primer extension of single nucleotide polymorphisms and its use in genetic analysis |
EP0812211A4 (de) * | 1994-03-18 | 1998-12-16 | Gen Hospital Corp | Erkennungsverfahren durch rflp |
US6110709A (en) * | 1994-03-18 | 2000-08-29 | The General Hospital Corporation | Cleaved amplified modified polymorphic sequence detection methods |
FR2718461B1 (fr) * | 1994-04-07 | 1996-05-15 | Cis Bio Int | Procédé de détection d'un site de restriction dans une séquence d'ADN. |
US5643723A (en) * | 1994-05-26 | 1997-07-01 | Roche Molecular Systems, Inc. | Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens |
US5545527A (en) * | 1994-07-08 | 1996-08-13 | Visible Genetics Inc. | Method for testing for mutations in DNA from a patient sample |
CA2163393C (en) * | 1994-11-30 | 2003-04-22 | Colleen Marie Nycz | Amplification and detection of mycobacteria nucleic acids |
US6787304B1 (en) | 1994-12-28 | 2004-09-07 | Georgetown University | Fluorometric assay for detecting nucleic acid cleavage |
WO1996021144A1 (en) * | 1994-12-30 | 1996-07-11 | Georgetown University | Fluorometric assay for detecting nucleic acid cleavage |
US20030165908A1 (en) * | 1994-12-30 | 2003-09-04 | Georgetown University | Fluorometric assay for detecting nucleic acid cleavage |
US6428955B1 (en) | 1995-03-17 | 2002-08-06 | Sequenom, Inc. | DNA diagnostics based on mass spectrometry |
US20060063193A1 (en) * | 1995-04-11 | 2006-03-23 | Dong-Jing Fu | Solid phase sequencing of double-stranded nucleic acids |
US7803529B1 (en) | 1995-04-11 | 2010-09-28 | Sequenom, Inc. | Solid phase sequencing of biopolymers |
US5830655A (en) | 1995-05-22 | 1998-11-03 | Sri International | Oligonucleotide sizing using cleavable primers |
US5830657A (en) * | 1996-05-01 | 1998-11-03 | Visible Genetics Inc. | Method for single-tube sequencing of nucleic acid polymers |
US5888736A (en) * | 1995-12-22 | 1999-03-30 | Visible Genetics, Inc. | Method, compositions and kit for detection and identification of microorganisms |
US5789168A (en) * | 1996-05-01 | 1998-08-04 | Visible Genetics Inc. | Method for amplification and sequencing of nucleic acid polymers |
US7122364B1 (en) * | 1998-03-24 | 2006-10-17 | Third Wave Technologies, Inc. | FEN endonucleases |
US6706471B1 (en) | 1996-01-24 | 2004-03-16 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
US7195871B2 (en) * | 1996-01-24 | 2007-03-27 | Third Wave Technologies, Inc | Methods and compositions for detecting target sequences |
US6875572B2 (en) | 1996-01-24 | 2005-04-05 | Third Wave Technologies, Inc. | Nucleic acid detection assays |
US5985557A (en) | 1996-01-24 | 1999-11-16 | Third Wave Technologies, Inc. | Invasive cleavage of nucleic acids |
US20080160524A1 (en) * | 1996-01-24 | 2008-07-03 | Third Wave Technologies, Inc. | Methods and Compositions for Detecting Target Sequences |
US5824476A (en) * | 1996-02-28 | 1998-10-20 | City Of Hope | Competitive hybridization technique |
US5861483A (en) * | 1996-04-03 | 1999-01-19 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
US6083699A (en) * | 1996-05-01 | 2000-07-04 | Visible Genetics Inc. | Method for bi-directional sequencing of nucleic acid polymers |
US6214555B1 (en) | 1996-05-01 | 2001-04-10 | Visible Genetics Inc. | Method compositions and kit for detection |
US6413718B1 (en) | 1996-05-01 | 2002-07-02 | Visible Genetics Inc. | Method for sequencing of nucleic acid polymers |
US5853990A (en) * | 1996-07-26 | 1998-12-29 | Edward E. Winger | Real time homogeneous nucleotide assay |
US6297027B1 (en) | 1996-07-31 | 2001-10-02 | Purina Mills, Inc. | Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof |
US6277592B1 (en) | 1996-07-31 | 2001-08-21 | Purina Mills, Inc. | Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
US20050064439A1 (en) * | 1996-08-22 | 2005-03-24 | Johanna Bergmann | Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
US6140053A (en) * | 1996-11-06 | 2000-10-31 | Sequenom, Inc. | DNA sequencing by mass spectrometry via exonuclease degradation |
CA2270132A1 (en) | 1996-11-06 | 1998-05-14 | Sequenom, Inc. | Dna diagnostics based on mass spectrometry |
US6133436A (en) | 1996-11-06 | 2000-10-17 | Sequenom, Inc. | Beads bound to a solid support and to nucleic acids |
ATE259056T1 (de) | 1996-11-06 | 2004-02-15 | Sequenom Inc | Verfahren zur massenspektrometrie |
CA2273204C (en) | 1996-11-29 | 2008-10-14 | Third Wave Technologies, Inc. | Fen-1 endonucleases, mixtures and cleavage methods |
US6475724B1 (en) * | 1997-01-28 | 2002-11-05 | The Regents Of The University Of California | Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
US6171788B1 (en) | 1997-01-28 | 2001-01-09 | The Regents Of The University Of California | Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
US7138511B1 (en) | 1997-01-28 | 2006-11-21 | The Regents Of The University Of California | Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
US6143496A (en) | 1997-04-17 | 2000-11-07 | Cytonix Corporation | Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly |
US6514755B1 (en) * | 1998-08-18 | 2003-02-04 | Regents Of The University Of Minnesota | SCA7 gene and methods of use |
US6280938B1 (en) | 1997-08-19 | 2001-08-28 | Regents Of The University Of Minnesota | SCA7 gene and method of use |
US6207370B1 (en) | 1997-09-02 | 2001-03-27 | Sequenom, Inc. | Diagnostics based on mass spectrometric detection of translated target polypeptides |
US6518017B1 (en) * | 1997-10-02 | 2003-02-11 | Oasis Biosciences Incorporated | Combinatorial antisense library |
US20030165888A1 (en) * | 2001-07-18 | 2003-09-04 | Brown Bob D. | Oligonucleotide probes and primers comprising universal bases for diagnostic purposes |
US6103468A (en) * | 1997-10-07 | 2000-08-15 | Labatt Brewing Company Limited | Rapid two-stage polymerase chain reaction method for detection of lactic acid bacteria in beer |
US8182991B1 (en) | 1997-11-26 | 2012-05-22 | Third Wave Technologies, Inc. | FEN-1 endonucleases, mixtures and cleavage methods |
US6723564B2 (en) | 1998-05-07 | 2004-04-20 | Sequenom, Inc. | IR MALDI mass spectrometry of nucleic acids using liquid matrices |
US6242223B1 (en) | 1998-09-28 | 2001-06-05 | Creighton University | Primers for use in detecting beta-lactamases |
US6524791B1 (en) | 1998-10-28 | 2003-02-25 | Regents Of The University Of Minnesota | Spinocerebellar ataxia type 8 and methods of detection |
EP1173614A4 (de) * | 1999-04-08 | 2003-10-29 | Oasis Biosciences Inc | Antisense oligonukleotide enthaltend universelle und/oder degenerierte basen |
NZ516278A (en) | 1999-06-22 | 2004-03-26 | Invitrogen Corp | Improved primers and methods for the detection and discrimination of nucleic acids |
US6830902B1 (en) | 1999-07-02 | 2004-12-14 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
WO2001013086A2 (en) * | 1999-08-13 | 2001-02-22 | Brandeis University | Detection of nucleic acids |
DK1218542T3 (da) | 1999-09-13 | 2004-08-02 | Nugen Technologies Inc | Fremgangsmåder og sammensætninger til lineær isotermisk amplifikation af polynukleotidsekvenser |
US6692918B2 (en) | 1999-09-13 | 2004-02-17 | Nugen Technologies, Inc. | Methods and compositions for linear isothermal amplification of polynucleotide sequences |
US7118860B2 (en) | 1999-10-29 | 2006-10-10 | Stratagene California | Methods for detection of a target nucleic acid by capture |
US7824859B2 (en) * | 1999-10-29 | 2010-11-02 | Cytyc Corporation | Methods for detection of a target nucleic acid by forming a cleavage structure using an RNA polymerase |
US6893819B1 (en) * | 2000-11-21 | 2005-05-17 | Stratagene California | Methods for detection of a nucleic acid by sequential amplification |
US7838225B2 (en) * | 1999-10-29 | 2010-11-23 | Hologic, Inc. | Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase |
EP2944695B1 (de) | 1999-12-16 | 2017-02-15 | Monsanto Technology LLC | Neue pflanzliche expressionskonstrukte |
CA2332729A1 (en) * | 2000-02-17 | 2001-08-17 | Amsterdam Support Diagnostics B.V. | Reducing background in hybridisation reactions |
AU2001266861A1 (en) * | 2000-06-12 | 2001-12-24 | Randell L. Mills | Photocleavable prodrugs for selective drug delivery |
JP2004513617A (ja) * | 2000-06-26 | 2004-05-13 | ニューゲン テクノロジーズ, インコーポレイテッド | 転写に基づく核酸増幅のための方法および組成物 |
US7846733B2 (en) * | 2000-06-26 | 2010-12-07 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
EP1197550A3 (de) * | 2000-08-25 | 2002-11-20 | Pfizer Products Inc. | Methoden und Zusammensetzungen zur Diagnose unde Behandlung von Krankheiten an denen Angiogenese beteiligt ist |
US6929911B2 (en) * | 2000-11-01 | 2005-08-16 | The Board Of Trustees Of The Leland Stanford Junior University | Method for determining genetic affiliation, substructure and gene flow within human populations |
WO2002070755A2 (en) * | 2000-11-15 | 2002-09-12 | Third Wave Technologies, Inc. | Fen endonucleases |
WO2002048401A2 (en) | 2000-12-11 | 2002-06-20 | Alexion Pharmaceuticals, Inc. | Nested oligonucleotides containing hairpin for nucleic acid amplification |
AU2002228974A1 (en) | 2000-12-13 | 2002-06-24 | Nugen Technologies, Inc | Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
US6794141B2 (en) | 2000-12-22 | 2004-09-21 | Arcturus Bioscience, Inc. | Nucleic acid amplification |
US6635451B2 (en) * | 2001-01-25 | 2003-10-21 | Abbott Laboratories | Desaturase genes and uses thereof |
MXPA02012739A (es) | 2001-03-09 | 2004-04-20 | Nugen Technologies Inc | Metodos y composiciones para amplificacion de secuencias de arn. |
JP2005508135A (ja) * | 2001-03-09 | 2005-03-31 | ニューゲン テクノロジーズ, インコーポレイテッド | Rna配列の増幅のための方法および組成物 |
EP1950305A1 (de) | 2001-05-09 | 2008-07-30 | Monsanto Technology, LLC | Tyr-A-Gene und ihre Verwendung |
US20030129607A1 (en) * | 2001-05-25 | 2003-07-10 | Invitrogen Corporation | Compositions and methods for extension of nucleic acids |
WO2002100246A2 (en) * | 2001-06-12 | 2002-12-19 | Board Of Regents, The University Of Texas System | Methods of detecting, diagnosing and treating cancer and identifying neoplastic progression |
US6995841B2 (en) | 2001-08-28 | 2006-02-07 | Rice University | Pulsed-multiline excitation for color-blind fluorescence detection |
DE60234369D1 (de) * | 2001-09-19 | 2009-12-24 | Alexion Pharma Inc | Manipulierte matrizen und ihre verwendung bei der single-primer-amplifikation |
US7414111B2 (en) * | 2001-09-19 | 2008-08-19 | Alexion Pharmaceuticals, Inc. | Engineered templates and their use in single primer amplification |
US20030165859A1 (en) * | 2001-10-23 | 2003-09-04 | Invitrogen Corporation | Primers and methods for the detection and discrimination of nucleic acids |
US6942972B2 (en) * | 2001-10-24 | 2005-09-13 | Beckman Coulter, Inc. | Efficient synthesis of protein-oligonucleotide conjugates |
US7045319B2 (en) * | 2001-10-30 | 2006-05-16 | Ribomed Biotechnologies, Inc. | Molecular detection systems utilizing reiterative oligonucleotide synthesis |
US20040054162A1 (en) * | 2001-10-30 | 2004-03-18 | Hanna Michelle M. | Molecular detection systems utilizing reiterative oligonucleotide synthesis |
US20030119000A1 (en) * | 2001-11-05 | 2003-06-26 | Jon Polansky | Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma |
US7222059B2 (en) * | 2001-11-15 | 2007-05-22 | Siemens Medical Solutions Diagnostics | Electrophoretic trace simulator |
US20040002080A1 (en) * | 2001-12-14 | 2004-01-01 | Creighton University | Primers for use in detecting beta-lactamases |
US7211656B2 (en) * | 2002-01-30 | 2007-05-01 | Abbott Laboratories | Desaturase genes, enzymes encoded thereby, and uses thereof |
ES2222775B1 (es) * | 2002-01-31 | 2006-12-16 | Laboratorios Indas, S.A. | Procedimiento para la deteccion de una predisposicion a una enfermedad cardiovascular. |
US20060246434A1 (en) * | 2002-03-15 | 2006-11-02 | Erlander Mark G | Nucleic acid amplification |
EP1504106B1 (de) | 2002-05-15 | 2010-07-07 | Monsanto Technology LLC | Verfahren zur erhöhung des samengewichtes in einer pflanze |
US7045291B2 (en) * | 2002-05-17 | 2006-05-16 | Creighton University | Multiplex PCR for the detection of AmpC beta-lactamase genes |
CA2495051C (en) | 2002-08-05 | 2012-04-24 | Quanta Biosciences | Improved compositions for in vitro amplification of nucleic acids |
US7803536B2 (en) * | 2002-09-20 | 2010-09-28 | Integrated Dna Technologies, Inc. | Methods of detecting fluorescence with anthraquinone quencher dyes |
US7205147B2 (en) | 2002-09-23 | 2007-04-17 | E.I. Du Pont De Nemours And Company | Nucleic acids encoding ryanodine receptors |
US7094879B2 (en) | 2002-10-02 | 2006-08-22 | Abbott Laboratories | Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof |
EP1418241A1 (de) * | 2002-11-08 | 2004-05-12 | PrimaGen Holding B.V. | Methode zur Quantifizierung des Verhältnisses zweier Nukleinsäuresequenzen |
EP1576138B1 (de) | 2002-11-15 | 2017-02-01 | Idenix Pharmaceuticals LLC. | 2'-methyl nukleoside in kombination mit interferon und flaviviridae-mutation |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
KR100890885B1 (ko) | 2003-03-31 | 2009-03-31 | 에프. 호프만-라 로슈 아게 | 일본 뇌염 바이러스 혈청군의 구성원을 포함하는, 특정플라비바이러스 검출용 조성물 및 방법 |
EP1613778B1 (de) * | 2003-04-14 | 2014-11-26 | Nugen Technologies, Inc. | Globale amplifizierung unter verwendung von zufallsgeprimeten zusammen gesetzten primern |
US20050080260A1 (en) * | 2003-04-22 | 2005-04-14 | Mills Randell L. | Preparation of prodrugs for selective drug delivery |
WO2004098386A2 (en) * | 2003-05-01 | 2004-11-18 | Gen-Probe Incorporated | Oligonucleotides comprising a molecular switch |
US20060057766A1 (en) * | 2003-07-08 | 2006-03-16 | Quanxi Jia | Method for preparation of semiconductive films |
US20050059035A1 (en) * | 2003-09-09 | 2005-03-17 | Quest Diagnostics Incorporated | Methods and compositions for the amplification of mutations in the diagnosis of cystic fibrosis |
US20070248954A1 (en) * | 2003-09-10 | 2007-10-25 | Creighton University | Primers for Use in Detecting Beta-Lactamases |
KR20070012779A (ko) * | 2003-10-29 | 2007-01-29 | 리보메드 바이오테그놀로지스 인코포레이티드 | 반복적 올리고뉴클레오티드 합성을 위한 조성물, 방법 및검출 기법 |
WO2005049849A2 (en) | 2003-11-14 | 2005-06-02 | Integrated Dna Technologies, Inc. | Fluorescence quenching azo dyes, their methods of preparation and use |
US7807874B2 (en) | 2003-12-10 | 2010-10-05 | Monsanto Technology Llc | Stress tolerant plants and methods thereof |
US8338578B1 (en) | 2004-03-05 | 2012-12-25 | Quest Diagnostics Investments Incorporated | Cystic fibrosis gene mutations |
CA2568689A1 (en) * | 2004-06-04 | 2005-12-15 | Fluxome Sciences A/S | Metabolically engineered cells for the production of polyunsaturated fatty acids |
US7456270B2 (en) * | 2004-09-01 | 2008-11-25 | Abbott Laboratories | Δ6-desaturase genes and uses thereof |
US7678824B2 (en) | 2004-09-14 | 2010-03-16 | The Regents Of The University Of Colorado, A Body Corporate | Methods for treatment with bucindolol based on genetic targeting |
US20060063187A1 (en) * | 2004-09-15 | 2006-03-23 | Hotamisligil Gokhan S | Modulation of XBP-1 activity for treatment of metabolic disorders |
US20060105348A1 (en) * | 2004-11-15 | 2006-05-18 | Lee Jun E | Compositions and methods for the detection and discrimination of nucleic acids |
US20060275792A1 (en) * | 2004-11-15 | 2006-12-07 | Lee Jun E | Enhancement of nucleic acid amplification using double-stranded DNA binding proteins |
US7790363B2 (en) * | 2005-02-07 | 2010-09-07 | Abbott Laboratories Inc. | Diagnostic test for vitamin B12 |
US20060228721A1 (en) * | 2005-04-12 | 2006-10-12 | Leamon John H | Methods for determining sequence variants using ultra-deep sequencing |
CA2604095A1 (en) | 2005-04-12 | 2006-10-19 | 454 Life Sciences Corporation | Methods for determining sequence variants using ultra-deep sequencing |
US8293477B2 (en) | 2005-04-15 | 2012-10-23 | Cornell University | Methods for modulating bone formation and mineralization by modulating KRC activity |
US8624027B2 (en) | 2005-05-12 | 2014-01-07 | Abbvie Inc. | Combination therapy for treating cancer and diagnostic assays for use therein |
CA2601554A1 (en) | 2005-05-20 | 2006-11-30 | Integrated Dna Technologies, Inc. | Compounds and methods for labeling oligonucleotides |
CN101356285A (zh) * | 2005-08-16 | 2009-01-28 | 梅洛根有限责任公司 | 鉴定陨石色基因的方法 |
US7838646B2 (en) * | 2005-08-18 | 2010-11-23 | Quest Diagnostics Investments Incorporated | Cystic fibrosis transmembrane conductance regulator gene mutations |
WO2007030759A2 (en) | 2005-09-07 | 2007-03-15 | Nugen Technologies, Inc. | Improved nucleic acid amplification procedure |
WO2007037282A1 (ja) * | 2005-09-27 | 2007-04-05 | Eisai R & D Management Co., Ltd. | 微小粒子に自己集合体を形成させる方法及び標的分析物の検出方法 |
KR20180058863A (ko) | 2005-11-30 | 2018-06-01 | 애브비 인코포레이티드 | 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도 |
US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
KR100652903B1 (ko) * | 2005-12-21 | 2006-12-04 | 한국과학기술연구원 | 초흡수성 고분자를 함유한 제습제의 제조 방법 및 그 제조장치 |
US7285388B1 (en) * | 2006-04-07 | 2007-10-23 | Merlogen, Llc | Methods for identification of alport syndrome |
US20070256148A1 (en) * | 2006-04-26 | 2007-11-01 | Katz David A | DEP2 and its uses in major depressive disorder and other related disorders |
US8933209B2 (en) * | 2006-04-26 | 2015-01-13 | Abbvie Inc. | Dep2 and its uses in major depressive disorder and other related disorders |
CA2649456A1 (en) * | 2006-05-25 | 2007-12-06 | Creighton University | Primers for use in detecting metallo-beta-lactamases |
JP2009538137A (ja) | 2006-05-25 | 2009-11-05 | モンサント テクノロジー エルエルシー | ダイズの病害耐性量的形質遺伝子座を同定する方法およびその組成物 |
US8232049B2 (en) * | 2006-09-29 | 2012-07-31 | Case Western Reserve University | Method for detecting small oligonucleotides |
AU2007324117B2 (en) | 2006-10-05 | 2014-03-06 | Massachussetts Institute Of Technology | Multifunctional encoded particles for high-throughput analysis |
US7777877B2 (en) * | 2006-10-20 | 2010-08-17 | California Institute Of Technology | High efficiency coupling optics for pumping and detection of fluorescence |
KR100803055B1 (ko) * | 2006-11-03 | 2008-02-18 | 한국과학기술원 | 구면베어링 조립체의 제조장치 및 그 제조방법 |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
US7794937B2 (en) * | 2006-12-22 | 2010-09-14 | Quest Diagnostics Investments Incorporated | Cystic fibrosis transmembrane conductance regulator gene mutations |
US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
CN101680027A (zh) * | 2007-03-16 | 2010-03-24 | 454生命科学公司 | 检测hiv耐药变异体的系统和方法 |
EP2134870B1 (de) * | 2007-03-28 | 2014-02-26 | Monsanto Technology, LLC | Nutzen von snp-markern in zusammenhang mit genomischen bereichen für reife und wachstumsgewohnheit wichtiger sojabohnenarten |
BRPI0815841A2 (pt) | 2007-08-29 | 2015-09-01 | Monsanto Technology Llc | Métodos e composições para melhoramento de traços preferidos. |
US8716190B2 (en) | 2007-09-14 | 2014-05-06 | Affymetrix, Inc. | Amplification and analysis of selected targets on solid supports |
US9388457B2 (en) | 2007-09-14 | 2016-07-12 | Affymetrix, Inc. | Locus specific amplification using array probes |
US20090203531A1 (en) * | 2008-02-12 | 2009-08-13 | Nurith Kurn | Method for Archiving and Clonal Expansion |
US8268981B2 (en) * | 2008-03-06 | 2012-09-18 | Abbott Laboratories | Plasmodium malariae and plasmodium ovale genes and uses thereof |
US8030471B2 (en) * | 2008-03-06 | 2011-10-04 | Abbott Laboratories | Plasmodium malariae and Plasmodium ovale genes and uses thereof |
EP2274448B1 (de) * | 2008-03-15 | 2013-09-18 | Hologic, Inc. | Zusammensetzungen und verfahren zur analyse von nukleinsäuremolekülen während amplifikationsreaktionen |
WO2009117698A2 (en) | 2008-03-21 | 2009-09-24 | Nugen Technologies, Inc. | Methods of rna amplification in the presence of dna |
US8669414B2 (en) | 2008-04-24 | 2014-03-11 | Monsanto Technology Llc | Method to identify Asian soybean rust resistance quantitative trait loci in soybean and compositions thereof |
US8242243B2 (en) | 2008-05-15 | 2012-08-14 | Ribomed Biotechnologies, Inc. | Methods and reagents for detecting CpG methylation with a methyl CpG binding protein (MBP) |
WO2010009060A2 (en) * | 2008-07-13 | 2010-01-21 | Ribomed Biotechnologies, Inc. | Molecular beacon-based methods for detection of targets using abscription |
UA106212C2 (uk) * | 2008-10-06 | 2014-08-11 | Ебботт Лебораторіз | Гени дельта-8-десатурази, ферменти, що ними кодуються, та їх застосування |
US8288124B2 (en) * | 2008-11-20 | 2012-10-16 | Abbott Laboratories | Cloning, expression and purification of recombinant porcine intrinsic factor for use in diagnostic assay |
WO2010068738A1 (en) | 2008-12-10 | 2010-06-17 | Dana-Farber Cancer Institute, Inc. | Mek mutations conferring resistance to mek inhibitors |
JP2012514461A (ja) * | 2009-01-06 | 2012-06-28 | ヨウ,キミン | 標的核酸の交差プライミング増幅 |
US20100196907A1 (en) * | 2009-01-31 | 2010-08-05 | Abbott Laboratories | Markers to predict and monitor response to aurora kinase b inhibitor therapy |
CN102388151A (zh) | 2009-02-11 | 2012-03-21 | 雅培制药有限公司 | 用于鉴定、分类和监控具有bcl-2家族抑制剂抗性肿瘤和癌症的受试者的方法和组合物 |
AU2010225937B2 (en) | 2009-03-15 | 2014-09-18 | Ribomed Biotechnologies, Inc. | Abscription based molecular detection |
US8063193B2 (en) | 2009-03-27 | 2011-11-22 | Abbott Laboratories | Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof |
SI2430452T1 (sl) | 2009-05-14 | 2014-11-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Diagnosticiranje in zdravljenja karcinoma na osnovi genotipa odc1 |
US20100299773A1 (en) * | 2009-05-20 | 2010-11-25 | Monsanto Technology Llc | Methods and compositions for selecting an improved plant |
CA2766794A1 (en) | 2009-06-30 | 2011-01-06 | Abbott Laboratories | Markers of xmrv infection and uses thereof |
US8188335B2 (en) | 2009-07-17 | 2012-05-29 | Abbott Laboratories | Δ9-elongase for production of polyunsaturated fatty acid-enriched oils |
WO2011032088A1 (en) | 2009-09-11 | 2011-03-17 | Arca Biopharma, Inc. | Polymorphisms in the pde3a gene |
ES2587191T3 (es) | 2009-12-23 | 2016-10-21 | Arca Biopharma, Inc. | Métodos y composiciones para enfermedades y afecciones cardiovasculares |
US9745589B2 (en) | 2010-01-14 | 2017-08-29 | Cornell University | Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination |
JP2013518590A (ja) | 2010-02-02 | 2013-05-23 | アボツト・バイオテクノロジー・リミテツド | TNF−α阻害剤を用いる処置に対する応答性を予測するための方法および組成物 |
EP3028699B1 (de) | 2010-02-25 | 2018-03-21 | Dana-Farber Cancer Institute, Inc. | Braf-mutationen für resistenz gegen braf-inhibitoren |
AU2011230496B2 (en) | 2010-03-26 | 2015-09-17 | Integrated Dna Technologies, Inc. | Methods for enhancing nucleic acid hybridization |
US20120108799A1 (en) | 2010-09-07 | 2012-05-03 | Integrated Dna Technologies, Inc. | Modifications for Antisense Compounds |
US9506057B2 (en) | 2010-03-26 | 2016-11-29 | Integrated Dna Technologies, Inc. | Modifications for antisense compounds |
US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
EP2568978B1 (de) | 2010-05-14 | 2019-04-24 | Arizona Board of Regents on Behalf of University of Arizona | Krebsvorbeugung und -behandlung basierend auf polyamin-nahrungsmittelgehalt |
WO2011156432A2 (en) | 2010-06-07 | 2011-12-15 | Firefly Bioworks, Inc. | Scanning multifunctional particles |
WO2011156588A1 (en) | 2010-06-09 | 2011-12-15 | Dana-Farber Cancer Institute, Inc. | A mek 1 mutation conferring resistance to raf and mek inhibitors |
CN103298833B (zh) | 2010-08-14 | 2015-12-16 | Abbvie公司 | β淀粉样蛋白结合蛋白 |
WO2012024513A2 (en) | 2010-08-18 | 2012-02-23 | Abbott Laboratories | Molecular detection of xmrv infection |
WO2012024518A1 (en) | 2010-08-18 | 2012-02-23 | Abbott Laboratories | Molecular detection of xmrv infection |
US9956236B2 (en) | 2011-02-07 | 2018-05-01 | Cornell University | Methods for increasing immune responses using agents that directly bind to and activate IRE-1 |
AU2012214312A1 (en) * | 2011-02-09 | 2013-08-22 | Bio-Rad Laboratories, Inc. | Analysis of nucleic acids |
US9145580B2 (en) * | 2011-04-02 | 2015-09-29 | New England Biolabs, Inc. | Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides |
US10172305B2 (en) | 2011-04-29 | 2019-01-08 | Monsanto Technology Llc | Diagnostic molecular markers for seed lot purity traits in soybeans |
EP2750495B1 (de) | 2011-08-31 | 2019-02-27 | Seminis Vegetable Seeds, Inc. | Verfahren und zusammensetzungen zur aufrechterhaltung der festigkeit von wassermelonen |
JO3766B1 (ar) | 2011-10-20 | 2021-01-31 | Novartis Ag | منشط مستقبل أسيتيل كولين الفا - 7 النيكوتيني |
US10314253B2 (en) | 2012-12-04 | 2019-06-11 | Seminis Vegetable Seeds, Inc. | Methods and compositions for watermelon sex expression |
CA2894384C (en) | 2012-12-11 | 2018-03-06 | Novartis Ag | Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment |
US10294489B2 (en) | 2013-03-15 | 2019-05-21 | Board Of Trustees Of Southern Illinois University | Soybean resistant to cyst nematodes |
US10059999B2 (en) | 2013-06-10 | 2018-08-28 | Monsanto Technology Llc | Molecular markers associated with soybean tolerance to low iron growth conditions |
CN105555972B (zh) | 2013-07-25 | 2020-07-31 | 伯乐生命医学产品有限公司 | 遗传测定 |
EP3049521B1 (de) | 2013-09-25 | 2019-03-06 | Cornell University | Verbindungen zur induzierung von antitumorimmunität und verfahren dafür |
NZ735461A (en) | 2013-11-27 | 2020-05-29 | Seminis Vegetable Seeds Inc | Disease resistance loci in onion |
US10260111B1 (en) | 2014-01-20 | 2019-04-16 | Brett Eric Etchebarne | Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample |
WO2015120130A1 (en) | 2014-02-07 | 2015-08-13 | Novartis Ag | Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy |
CN110607321A (zh) | 2014-02-21 | 2019-12-24 | 先正达参股股份有限公司 | 与玉米增加的能育性相关的遗传基因座 |
NZ630710A (en) | 2014-02-27 | 2016-03-31 | Seminis Vegetable Seeds Inc | Compositions and methods for peronospora resistance in spinach |
US10316369B2 (en) | 2014-06-27 | 2019-06-11 | Seminis Vegetable Seeds, Inc. | Methods and assays for male sterile watermelon |
EP3005862A1 (de) | 2014-10-10 | 2016-04-13 | Seminis Vegetable Seeds, Inc. | Melonenpflanzen mit verbesserter krankheitstoleranz |
US10448595B2 (en) | 2015-09-03 | 2019-10-22 | Seminis Vegetable Seeds, Inc. | Downy mildew resistant lettuce plants |
EP3199642A1 (de) | 2016-02-01 | 2017-08-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Pflanzenzucht mithilfe von sequenzierung mit grossem durchsatz |
MX2021012977A (es) | 2016-03-24 | 2022-10-03 | Cothera Biosciences Inc | Tratamiento del cáncer con tg02. |
BR112018070859A2 (pt) | 2016-04-12 | 2019-02-05 | Univ Michigan Regents | degradantes da proteína de bet |
CA3036841A1 (en) | 2016-09-13 | 2018-03-22 | The Regents Of The University Of Michigan | Fused 1,4-diazepines as bet protein degraders |
AU2017326171B2 (en) | 2016-09-13 | 2021-12-09 | The Regents Of The University Of Michigan | Fused 1,4-oxazepines as BET protein degraders |
AU2017232187B2 (en) | 2016-09-30 | 2023-11-09 | Seminis Vegetable Seeds, Inc. | Xanthomonas resistant brassica oleracea plants |
EP3669279A4 (de) | 2017-08-14 | 2021-05-05 | Epizyme, Inc. | Verfahren zur behandlung von krebs durch hemmung von setd2 |
AU2018317865B2 (en) | 2017-08-18 | 2023-03-16 | Cothera Bioscience, Inc. | Polymorphic form of TG02 |
WO2019055444A1 (en) | 2017-09-13 | 2019-03-21 | The Regents Of The University Of Michigan | DEGRADATION AGENTS OF BROMODOMAIN BET PROTEIN WITH CLEAR BINDERS |
AU2019356772A1 (en) | 2018-10-08 | 2021-04-01 | The Regents Of The University Of Michigan | Small molecule MDM2 protein degraders |
WO2020150144A1 (en) | 2019-01-15 | 2020-07-23 | Seminis Vegetable Seeds, Inc. | Green bean plants with improved disease resistance |
JP2022536419A (ja) | 2019-06-12 | 2022-08-16 | ヴァンダービルト ユニバーシティー | アミノ酸輸送阻害剤及びその使用 |
CA3141414A1 (en) | 2019-06-12 | 2020-12-17 | Vanderbilt University | Dibenzylamines as amino acid transport inhibitors |
US11542513B2 (en) | 2019-09-26 | 2023-01-03 | Seminis Vegetable Seeds, Inc. | Lettuce plants having resistance to Nasonovia ribisnigri biotype Nr:1 |
AU2021204717A1 (en) | 2020-07-15 | 2022-02-03 | Seminis Vegetable Seeds, Inc. | Green Bean Plants with Improved Disease Resistance |
US20230193310A1 (en) | 2021-12-10 | 2023-06-22 | Seminis Vegetabe Seeds, Inc. | Lettuce plants having resistance to downy mildew |
US20230404003A1 (en) | 2022-06-21 | 2023-12-21 | Seminis Vegetable Seeds, Inc. | Novel qtls conferring resistance to cucumber mosaic virus |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4477577A (en) * | 1980-03-17 | 1984-10-16 | University Of Southern California | Non-contaminating direct serum assay of steroid hormones |
US4535058A (en) * | 1982-10-01 | 1985-08-13 | Massachusetts Institute Of Technology | Characterization of oncogenes and assays based thereon |
US4395486A (en) * | 1981-08-19 | 1983-07-26 | Medical College Of Ga. Research Inst., Inc. | Method for the direct analysis of sickle cell anemia |
US4717653A (en) * | 1981-09-25 | 1988-01-05 | Webster John A Jr | Method for identifying and characterizing organisms |
FR2519005B1 (fr) * | 1981-12-29 | 1985-10-25 | Pasteur Institut | Fragments d'adn marques a l'une au moins de leurs extremites par des ribonucleotides modifies reconnaissables par des molecules affines et procede pour realiser une analyse de tels fragments d'adn |
JPS6091999A (ja) * | 1983-10-25 | 1985-05-23 | Fujirebio Inc | ポリヌクレオチドの測定方法 |
US4745060A (en) * | 1984-12-28 | 1988-05-17 | Board Of Regents, The University Of Texas System | Methods and compositions for the detection of Familial Hypercholesterolemia |
-
1985
- 1985-03-28 US US06/716,982 patent/US4683194A/en not_active Expired - Fee Related
- 1985-04-29 CA CA000480314A patent/CA1242627A/en not_active Expired
- 1985-05-28 IL IL75327A patent/IL75327A/xx unknown
- 1985-05-28 DE DE8585106525T patent/DE3572693D1/de not_active Expired
- 1985-05-28 ES ES543547A patent/ES8608584A1/es not_active Expired
- 1985-05-28 DE DE198585106525T patent/DE164054T1/de active Pending
- 1985-05-28 EP EP85106525A patent/EP0164054B1/de not_active Expired
- 1985-05-29 JP JP60114408A patent/JPS6119500A/ja active Pending
- 1985-05-29 DK DK240285A patent/DK240285A/da not_active Application Discontinuation
- 1985-05-29 AU AU43083/85A patent/AU587189B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JPS6119500A (ja) | 1986-01-28 |
CA1242627A (en) | 1988-10-04 |
ES8608584A1 (es) | 1986-06-16 |
ES543547A0 (es) | 1986-06-16 |
IL75327A0 (en) | 1985-09-29 |
AU4308385A (en) | 1985-12-05 |
DK240285D0 (da) | 1985-05-29 |
DE3572693D1 (en) | 1989-10-05 |
DK240285A (da) | 1985-11-30 |
IL75327A (en) | 1990-02-09 |
AU587189B2 (en) | 1989-08-10 |
EP0164054A1 (de) | 1985-12-11 |
US4683194A (en) | 1987-07-28 |
EP0164054B1 (de) | 1989-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE164054T1 (de) | Verfahren zum nachweis von polymorphischen restriktionsstellen und nukleinsauren sequenzen. | |
DE60029876T2 (de) | Verfahren und Oligonukleotide zum Nachweis von Nukleinsäuresequenzvariationen | |
DE69233657T2 (de) | Drei Mikrosatelliten-Repeat-Polymorphe DNA-Marker mit hoher Informationsdichte | |
DE69531542T2 (de) | Ligase/polymerase-vermittelte analyse genetischer elemente von einzelnukleotid-polymorphismen und ihre verwendung in der genetischen analyse | |
DE69434066T2 (de) | Verfahren zur immobilisierung von nukleinsäuremolekülen | |
DE69333650T2 (de) | Neue anordnungn von oligonukleotiden und ihr nutzen zum sortieren, isolieren, sequenzieren und manipulieren von nukleinsäuren | |
EP1007741B1 (de) | Verfahren zur markierung von festen, flüssigen oder gasförmigen substanzen | |
DE69719557T2 (de) | Verbesserte erkennung von spezifischen nukleinsäuren | |
DE69233458T2 (de) | Nukleinsäuretypisierung durch polymeraseverlängerung von oligonukleotiden unter verwendung von terminator-mischungen | |
DE69527444T3 (de) | Glycosylase verwendende detektion von bestimmten nukleinsäuresequenzen | |
DE69729122T2 (de) | KüNSTLICHE FEHLHYBRIDISIERUNG | |
DE60118655T2 (de) | Sonden und Methoden zum Nachweis von Nukleinsäuren | |
US4865968A (en) | DNA sequencing | |
DE60025850T2 (de) | Verfahren zur erzeugung von oligonukleotiden, im besonderen zur detektion amplifizierter restriktionsfragmente, die durch aflp erhalten wurden | |
EP0438512B2 (de) | Verfahren zur analyse von längenpolymorphismen in dna-bereichen | |
DE602005000485T2 (de) | Nukleinsäurenachweisverfahren mittels mehreren Paaren von Donorflurophoren und Quenchemolekülen in derselben Sonde | |
KR870009024A (ko) | 폴리뉴클레오티드의 생산 방법 | |
PT82405B (pt) | Processo de hibridizacao de duas cadeias de oligonucleotidos complementares e sondas para a sua realizacao | |
DE602006000713T2 (de) | Verfahren zur Verbesserung der Unterscheidung von einer einzelnen Basenfehlanpaarung durch die Verwendung von "hurdle" DNAs und Sonden mit artifiziellen Fehlpaarungen | |
WO1997017461A2 (de) | Verfahren zur genomanalyse und mittel zur durchführung des verfahrens | |
DE3938853A1 (de) | Verfahren zum nachweis abweichender nukleotidsequenzen, hybridisierungssonden fuer dieses verfahren sowie derartige sonden enthaltender kit | |
WO2002024944A2 (de) | Verfahren zum nachweis mindestens einer nukleinsäuresequenz | |
DE60017750T2 (de) | Amplifizierungsverfahren zum Nachweis von zu bestimmenden Nucleinsäuren und Anwendung von Flourszenzenergieübertragung | |
EP1064407A1 (de) | Verfahren und vorrichtung zum nachweis einer nukleotidsequenz | |
DE19801661A1 (de) | Schnell-Detektionsverfahren für Organismen durch Längenbestimmung ausgewählter Nukleinsäurebereiche |